Our Research Studies
Browse clinical and real-world studies detailing Tirzee program quality, safety, & member adherence.
Journal of Digital Health • A. Khan, S. Riaz
Tirzepatide Once Weekly for the Treatment of Obesity | New England Journal of Medicine
March 27, 2024
International Journal of Telemedicine • F. Ahmed, R. Siddiqui
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial - The Lancet
March 27, 2024
International Journal of Telemedicine • F. Ahmed, R. Siddiqui
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial | Nature Medicine
March 27, 2024
Journal of Digital Health • A. Khan, S. Riaz
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial | Cardiology | JAMA | JAMA Network
March 27, 2024
Journal of Digital Health • A. Khan, S. Riaz
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity | New England Journal of Medicine
March 27, 2024
International Journal of Telemedicine • F. Ahmed, R. Siddiqui
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine
March 27, 2024
The science behind how Tirzee works
